QUOTIENT SCIENCES
LIVE

Serial Number

79417429

Owner

Quotient Sciences Limited

Attorney

Jonathan Soifer

Filing Date

Sep 17, 2024

Add to watchlist:

No watchlists yet
View on USPTO

QUOTIENT SCIENCES Trademark

Serial Number: 79417429

QUOTIENT SCIENCES is a trademark filed by Quotient Sciences Limited on September 17, 2024. The trademark is classified under Class 39 (Transportation & Storage), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Quotient Sciences Limited (4 trademarks)

Trent House Mere Way, Ruddington Fields Business P

Entity Type: 98

Trademark Details

Filing Date

September 17, 2024

Registration Date

Not Registered

Goods & Services

Contract packaging services in the nature of packaging and labelling of pharmaceutical and biopharmaceuticals for distribution on behalf of third parties; contract packaging and labelling for other in the nature of merchandise packaging and labelling for others; storage services, namely, warehousing and temperature controlled storage of goods for others; transportation logistics services, namely, arranging transportation of goods for others; packaging articles to the order and specification of others; contract packaging of pharmaceutical, biopharmaceutical and clinical supplies and materials for others

Clinical research in the field of pharmacology and medical research; medical and scientific research, namely, conducting clinical trials for others; medical research, namely, conducting clinical trials for others in the field of pharmaceutical and biopharmaceutical products; pharmaceutical and biopharmaceutical research services; pharmaceutical and biopharmaceutical testing services; research relating to science namely, scientific research; Scientific research in the nature of basic and clinical research in the fields of pharmacology, pharmaceuticals and biopharmaceuticals; Evaluation and analysis of the efficacy and dosages of pharmaceutical and biopharmaceutical products of others and dosages in the nature of analysis and evaluation of pharmaceutical and biopharmaceutical products and dosages of others to determine conformity with certification standards and to assure compliance with industry standards; pharmaceutical and biopharmaceutical product evaluation; providing medical and scientific research information in the field of pharmaceuticals, biopharmaceuticals and clinical trials; biological research; research and development of vaccines and medicines; pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical products development; pharmaceutical and biopharmaceutical formulation design and development services, namely development of pharmaceutical and biopharmaceutical preparations and medicines; pre-formulation screening services, namely conducting early evaluations in the field of new pharmaceutical and testing, inspection and research of pharmaceuticals; scientific research in the nature of conducting clinical trials for others for the purpose of optimisation of pharmaceutical and biopharmaceutical formulations and dosage through clinical testing; development of pharmaceutical and biopharmaceutical preparations and medicines, research and development of vaccines and medicines, product research and development, product development for others; Research relating to medicine, namely, medical research in the field of pharmacology; Medical research in the nature of basic and clinical research in the field of pharmacology; consultancy relating to testing, inspection and research of pharmaceuticals and biopharmaceuticals; consultancy in the field of pharmacology; clinical pharmacology, namely technical research, testing and consulting in the field of pharmaceutical and biopharmaceutical studies; laboratory research services relating to pharmaceuticals.

Custom manufacture of pharmaceuticals and biopharmaceuticals; custom manufacture of pharmaceuticals and biopharmaceuticals for clinical trial purposes; manufacturing services for clinical trials, namely manufacture of pharmaceuticals and biopharmaceuticals to order and/or specification of others; Providing information in the field of custom manufacturing and testing of pharmaceutical and biopharmaceutical products.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2025 TROA
REFUSAL PROCESSED BY IB
Jul 5, 2025 RFNT
ASSIGNED TO LIE
Jun 23, 2025 ALIE
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 14, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 14, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 14, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 13, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2025 REPR